These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 428112

  • 1. Evaluation of steroid laboratory tests and adrenal gland imaging with radiocholesterol in the aetiological diagnosis of Cushing's syndrome.
    Barbarino A, de Marinis L, Liberale I, Menini E.
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):107-21. PubMed ID: 428112
    [Abstract] [Full Text] [Related]

  • 2. The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
    Hashimoto K.
    Acta Med Okayama; 1975 Apr; 29(2):111-26. PubMed ID: 169671
    [Abstract] [Full Text] [Related]

  • 3. [Cushing's syndrome: a diagnostic strategy].
    Bouallouche A, Vermeulen C, Brerault JL, Fiet J, Julien R, Guillevin L.
    Sem Hop; 1984 Apr 05; 60(15):1083-8. PubMed ID: 6326300
    [Abstract] [Full Text] [Related]

  • 4. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O, Jørgensen H, Frey H, Norman N.
    Tidsskr Nor Laegeforen; 1989 Sep 20; 109(26):2678-82. PubMed ID: 2554527
    [Abstract] [Full Text] [Related]

  • 5. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May 20; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 6. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Sindler BH, Griffing GT, Melby JC.
    Am J Med; 1983 Apr 20; 74(4):657-62. PubMed ID: 6837591
    [Abstract] [Full Text] [Related]

  • 7. [Cushing's syndrome: diagnostic exploration].
    Tabarin A, Roger P.
    Presse Med; 1983 Apr 20; 23(1):43-8. PubMed ID: 8127815
    [Abstract] [Full Text] [Related]

  • 8. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 20; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 9. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
    Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1988 Aug 20; 29(2):167-78. PubMed ID: 2854761
    [Abstract] [Full Text] [Related]

  • 10. Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome.
    Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR.
    Br Med J (Clin Res Ed); 1984 Nov 03; 289(6453):1188-91. PubMed ID: 6437479
    [Abstract] [Full Text] [Related]

  • 11. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G, Thalassinos N.
    Clin Endocrinol (Oxf); 1999 Oct 03; 51(4):473-7. PubMed ID: 10583315
    [Abstract] [Full Text] [Related]

  • 12. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
    Majnik J, Szücs N, Patócs A, Tóth M, Balogh K, Varga I, Gláz E, Rácz K.
    J Endocrinol Invest; 2004 Sep 03; 27(8):747-53. PubMed ID: 15636428
    [Abstract] [Full Text] [Related]

  • 13. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A, Nakajo M, Tsuchimochi S, Nakabeppu Y, Umanodan T.
    Ann Nucl Med; 2000 Jun 03; 14(3):205-12. PubMed ID: 10921486
    [Abstract] [Full Text] [Related]

  • 14. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome.
    Newell-Price J, Trainer P, Perry L, Wass J, Grossman A, Besser M.
    Clin Endocrinol (Oxf); 1995 Nov 03; 43(5):545-50. PubMed ID: 8548938
    [Abstract] [Full Text] [Related]

  • 15. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 03; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 16. Assessment of adrenal glucocorticoid function. Which tests are appropriate for screening?
    Hasinski S.
    Postgrad Med; 1998 Jul 03; 104(1):61-4, 69-72. PubMed ID: 9676562
    [Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome: a review of diagnostic tests.
    Crapo L.
    Metabolism; 1979 Sep 03; 28(9):955-77. PubMed ID: 225638
    [Abstract] [Full Text] [Related]

  • 18. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM.
    Clin Endocrinol (Oxf); 1991 Aug 03; 35(2):169-78. PubMed ID: 1657460
    [Abstract] [Full Text] [Related]

  • 19. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO, de Herder WW, van der Lely AJ, de Jong FH, Lamberts SW.
    Clin Endocrinol (Oxf); 1997 Aug 03; 47(2):145-9. PubMed ID: 9302385
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone infusion testing in the diagnosis of Cushing's syndrome.
    Tran HA, Petrovsky N.
    Endocr J; 2005 Feb 03; 52(1):103-9. PubMed ID: 15758565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.